Aptevo Therapeutics Inc. Gain (Loss) on Disposition of Assets
Aptevo Therapeutics Inc. (APVO) reported Gain (Loss) on Disposition of Assets of $14.34 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2020-11-10
- 2020-09-30: Gain (Loss) on Disposition of Assets 9 month $14.34M.
- 2019-09-30: Gain (Loss) on Disposition of Assets 9 month $4.25M.
| Period end | Gain (Loss) on Disposition of Assets 9 month |
|---|---|
| 2020-09-30 | $14.34M 10-Q · filed 2020-11-10 |
| 2019-09-30 | $4.25M 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |